A multidimensional, iterative parallel synthesis effort identified a series of highly selective mGlu3 NAMs with submicromolar potency and good CNS penetration. Of these, ML337 resulted (mGlu3 IC50 = 593 nM, mGlu2 IC50 >30 μM) with B:P ratios of 0.92 (mouse) to 0.3 (rat). DMPK profiling and shallow SAR led to the incorporation of deuterium atoms to address a metabolic soft spot, which subsequently lowered both in vitro and in vivo clearance by >50%.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769689PMC
http://dx.doi.org/10.1021/jm400439tDOI Listing

Publication Analysis

Top Keywords

ml337 mglu3
8
discovery r-2-fluoro-4--4-methoxyphenylethynylphenyl
4
r-2-fluoro-4--4-methoxyphenylethynylphenyl 3-hydroxypiperidin-1-ylmethanone
4
3-hydroxypiperidin-1-ylmethanone ml337
4
mglu3 selective
4
selective cns
4
cns penetrant
4
penetrant negative
4
negative allosteric
4
allosteric modulator
4

Similar Publications

Background And Purpose: We recently proposed the existence of mGlu -preferring autoreceptors in spinal cord terminals and of mGlu -preferring autoreceptors in cortical terminals. This study aims to verify our previous conclusions and to extend their pharmacological characterization.

Experimental Approach: We studied the effect of LY566332, an mGlu receptor positive allosteric modulator (PAM), and of LY2389575, a selective mGlu receptor negative allosteric (NAM) modulator, on the mGlu agonist LY379268-mediated inhibition of glutamate exocytosis [measured as KCl-evoked release of preloaded [ H]-D-aspartate].

View Article and Find Full Text PDF

A multidimensional, iterative parallel synthesis effort identified a series of highly selective mGlu3 NAMs with submicromolar potency and good CNS penetration. Of these, ML337 resulted (mGlu3 IC50 = 593 nM, mGlu2 IC50 >30 μM) with B:P ratios of 0.92 (mouse) to 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!